GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Erech Finance Cahalacha Ltd (XTAE:EFNC) » Definitions » Debt-to-Revenue

Erech Finance Cahalacha (XTAE:EFNC) Debt-to-Revenue : 56.56 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Erech Finance Cahalacha Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Erech Finance Cahalacha's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₪12.65 Mil. Erech Finance Cahalacha's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₪4.32 Mil. Erech Finance Cahalacha's annualized Revenue for the quarter that ended in Dec. 2023 was ₪0.30 Mil. Erech Finance Cahalacha's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 56.56.


Erech Finance Cahalacha Debt-to-Revenue Historical Data

The historical data trend for Erech Finance Cahalacha's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Erech Finance Cahalacha Debt-to-Revenue Chart

Erech Finance Cahalacha Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.22 4.08 3.69 3.68 60.17

Erech Finance Cahalacha Semi-Annual Data
Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.33 4.11 12.02 90.90 56.56

Competitive Comparison of Erech Finance Cahalacha's Debt-to-Revenue

For the Medical Devices subindustry, Erech Finance Cahalacha's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Erech Finance Cahalacha's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Erech Finance Cahalacha's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Erech Finance Cahalacha's Debt-to-Revenue falls into.



Erech Finance Cahalacha Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Erech Finance Cahalacha's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(12.653 + 4.316) / 0.282
=60.17

Erech Finance Cahalacha's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(12.653 + 4.316) / 0.3
=56.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.


Erech Finance Cahalacha Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Erech Finance Cahalacha's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Erech Finance Cahalacha (XTAE:EFNC) Business Description

Traded in Other Exchanges
N/A
Address
Yakov Eliav 5, Downtown, Jerusalem, ISR
Erech Finance Cahalacha Ltd, formerly Insuline Medical Ltd is a medical device company. It develops & markets technologies to the clinical effectiveness of devices & drugs for the treatment of diabetes. Its products include the InsuPatch device for insulin pump users, & the InsuPad device for injection users. The InsuPad is a company's flagship product.

Erech Finance Cahalacha (XTAE:EFNC) Headlines

No Headlines